With 0.21 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.26 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $19.87 whereas the lowest price it dropped to was $19.06. The 52-week range on OFIX shows that it touched its highest point at $20.73 and its lowest point at $10.28 during that stretch. It currently has a 1-year price target of $24.40. Beta for the stock currently stands at 1.09.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OFIX was up-trending over the past week, with a rise of 1.38%, but this was up by 16.93% over a month. Three-month performance surged to 10.13% while six-month performance rose 34.53%. The stock gained 70.35% in the past year, while it has gained 41.91% so far this year. A look at the trailing 12-month EPS for OFIX yields -3.14 with Next year EPS estimates of -0.91. For the next quarter, that number is -0.27. This implies an EPS growth rate of 31.88% for this year and 67.67% for next year.
Float and Shares Shorts:
At present, 37.16 million OFIX shares are outstanding with a float of 36.88 million shares on hand for trading. On 2024-11-15, short shares totaled 1.66 million, which was 434.99999999999994 higher than short shares on 1728950400. In addition to Mr. Geoffrey C. Gillespie as the firm’s VP & Corporate Controller, Mr. Massimo Calafiore serves as its President, CEO, Director and Interim President of Global Spine.
Institutional Ownership:
Through their ownership of 0.92320997 of OFIX’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, OFIX reported revenue of $196606000.0 and operating income of -$16929000.0. The EBITDA in the recently reported quarter was -$2669000.0 and diluted EPS was -$0.71.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With OFIX analysts setting a high price target of 27.2 and a low target of 22.0, the average target price over the next 12 months is 24.4. Based on these targets, OFIX could surge 42.19% to reach the target high and rise by 15.0% to reach the target low. Reaching the average price target will result in a growth of 27.55% from current levels.
Analysts have provided yearly estimates in a range of -$2.80196 being high and -$2.81128 being low. For OFIX, this leads to a yearly average estimate of -$2.80667. The surprise factor in the prior quarter was -$0.19. Based on analyst estimates, the high estimate for the next quarter is -$0.01 and the low estimate is -$0.09. The average estimate for the next quarter is thus -$0.05.
